Clinical trial
Oral Lactoferrin Prophylaxis to Prevent Sepsis and Necrotising Enterocolitis of Very Low Birth Weight Neonates in Neonatal Intensive Care Unit and Effect on T-regulatory Cells.
NCT01287507 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Lactoferrin Prophylaxis to Prevent Sepsis and Necrotising Enterocolitis of Very Low Birth Weight Neonates in Neonatal Intensive Care Unit and Effect on T-regulatory Cells.
- Lead sponsor
- Ankara University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- December 31, 2011
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
late onset neonatal sepsis, necrotising enterocolitis, very low birth weight infants